Synthon Holdings BV-製薬・医療分野:企業M&A・提携分析

GlobalDataが発行した調査報告書(DATA8013341)
◆英語タイトル:Synthon Holdings BV - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013341
◆発行会社(リサーチ会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:30
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:オランダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
Synthon Holdings BV (Synthon) is an integrated pharmaceutical company which focuses on delivering affordable medicines through innovative science. The company undertakes the research, development, manufacture and distribution of generics, active pharmaceutical ingredients and biopharmaceutical products. It provides small molecule generic products in the therapeutic areas of allergy, anti-infective, cardiovascular, central nervous system, oncology, skeletal and urology. The company’s products are approved by regulatory agencies in over 90 countries. It operates research and development facilities and manufacturing facilities to carry out its operations. The company has presence in Chile, Czech Republic, Mexico, Russia, Spain, Argentina and the US. Synthon is headquartered in Nijmegen, the Netherlands.

Synthon Holdings BV – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Synthon Holdings BV, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Synthon Holdings BV, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Synthon Holdings BV, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Synthon Holdings BV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Synthon Holdings BV, Medical Devices Deals, 2011 to YTD 2017 9
Synthon Holdings BV, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Synthon Holdings BV, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Synthon Acquires LEX System From Biolex Therapeutics 11
Partnerships 13
Pfizer Enters into Agreement with Synthon 13
MAB Discovery Enters into Research Agreement with Synthon for Antibodies 14
Synthon Enters Into Drug Discovery Agreement With MIVAC Development 15
Synthon Enters Into Research And Development Agreement With MIVAC 16
Licensing Agreements 17
Synthon Biopharma Enters into Licensing Agreement with Sanquin Blood Supply Foundation 17
MacroGenics Enters into Licensing Agreement with Synthon Biopharma 18
Synthon Enters Into Licensing Agreement With Amgen And Watson Pharma For Trastuzumab 19
Asset Transactions 21
Mercachem to Acquire Laboratory and Pilot Scale Operations in Prague from Synthon 21
Acquisition 22
Synthon Acquires Syntarga 22
Synthon Holdings BV – Key Competitors 24
Synthon Holdings BV – Key Employees 25
Synthon Holdings BV – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 28
Clinical Trials 28
May 18, 2016: Synthon advances clinical evaluation of anti-HER2 ADC SYD985 in an expanded cohort of HER2-positive metastatic breast cancer patients 28
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
Synthon Holdings BV, Pharmaceuticals & Healthcare, Key Facts 2
Synthon Holdings BV, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Synthon Holdings BV, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Synthon Holdings BV, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Synthon Holdings BV, Deals By Therapy Area, 2011 to YTD 2017 8
Synthon Holdings BV, Medical Devices Deals, 2011 to YTD 2017 9
Synthon Holdings BV, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Synthon Acquires LEX System From Biolex Therapeutics 11
Pfizer Enters into Agreement with Synthon 13
MAB Discovery Enters into Research Agreement with Synthon for Antibodies 14
Synthon Enters Into Drug Discovery Agreement With MIVAC Development 15
Synthon Enters Into Research And Development Agreement With MIVAC 16
Synthon Biopharma Enters into Licensing Agreement with Sanquin Blood Supply Foundation 17
MacroGenics Enters into Licensing Agreement with Synthon Biopharma 18
Synthon Enters Into Licensing Agreement With Amgen And Watson Pharma For Trastuzumab 19
Mercachem to Acquire Laboratory and Pilot Scale Operations in Prague from Synthon 21
Synthon Acquires Syntarga 22
Synthon Holdings BV, Key Competitors 24
Synthon Holdings BV, Key Employees 25
Synthon Holdings BV, Subsidiaries 26

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Synthon Holdings BV-製薬・医療分野:企業M&A・提携分析(Synthon Holdings BV - Pharmaceuticals & Healthcare - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆